Rare diseases
Investigational molecules
Locations
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SlovakiaSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
SlovakiaStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
SlovakiaStudy of plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia
SlovakiaStudy of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems
SlovakiaStudy of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs
SlovakiaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
SlovakiaAssessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder
SlovakiaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
SlovakiaStudy of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels
SlovakiaStudy of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness
SlovakiaStudy on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma
SlovakiaTell us about your condition – we search every trial in Europe and connect you with the right site.
